Search Result "thalassaemia"
Cardiovascular Aspect of Beta-Thalassaemia
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 10 Issue: 1 Year: 2012 Page: 25-30
Author(s): Amar Taksande, Shakuntala Prabhu, Sumitra Venkatesh
Iron Overload and Glucose Metabolism in Subjects with β-thalassaemia Major : An Overview
Journal: Current Diabetes Reviews
Volume: 9 Issue: 4 Year: 2013 Page: 332-341
Author(s): Vincenzo De Sanctis,Ashraf Soliman,Mohamed Yassin
The Novel Role of the B-Cell Lymphoma/Leukemia 11A (BCL11A) Genein β-Thalassaemia Treatment
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 22 Issue: 4 Year: 2022 Page: 226-236
Author(s): Nahil Hassan Mahmoud Ahmed
Safety Profile of Oral Iron Chelator Deferiprone in Chinese Children with Transfusion-Dependent Thalassaemia
Journal: Current Drug Safety
Volume: 11 Issue: 2 Year: 2016 Page: 137-144
Author(s): Sebastian Botzenhardt, Chor W. Sing, Ian C.K. Wong, Godfrey Chi-Fung Chan, Lisa Y.L. Wong, Mariagrazia Felisi, Wolfgang Rascher, Adriana Ceci, Antje Neubert
The Design and Development of Deferiprone (L1) and Other Iron Chelators for Clinical Use: Targeting Methods and Application Prospects
Journal: Current Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2004 Page: 2161-2183
Author(s): G. J. Kontoghiorghes, K. Pattichis, K. Neocleous, A. Kolnagou
Editorial from Guest Editor [ Hot Topic:Current Status of Therapeutics and Preventive Measures for Patients with Thalassaemia and Sickle Cell Disease (Guest Editor: P.H. Reddy)]
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 10 Issue: 1 Year: 2012 Page: 2-2
Author(s): P. Hemachandra Reddy
Advances in Iron Overload Therapies. Prospects for Effective Use of Deferiprone (L1), Deferoxamine, the New Experimental Chelators ICL670, GT56-252, L1NAll and their Combinations
Journal: Current Medicinal Chemistry
Volume: 12 Issue: 2 Year: 2005 Page: 2663-2681
Author(s): George J. Kontoghiorghes, Eleni Eracleous, Charalambos Economides, Annita Kolnagou
Molecular Factors and Mechanisms Affecting Iron and Other Metal Excretion or Absorption in Health and Disease. The Role of Natural and Synthetic Chelators
Journal: Current Medicinal Chemistry
Volume: 12 Issue: 2 Year: 2005 Page: 2695-2709
Author(s): George J. Kontoghiorghes, Annita Kolnagou
Production of Lentivectors for Clinical Use
Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume: 13 Issue: 3 Year: 2013 Page: 165-175
Author(s): David Escors,Therese Liechtenstein,Noemi Perez-Janices,Idoia Blanco-Luquin,David Guerrero-Setas
Induced Pluripotent Stem Cell Technology: A Paradigm Shift in Medical Science for Drug Screening and Disease Modeling
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 39 Year: 2017 Page: 4368-4398
Author(s): Meera Nair,Sardul Singh Sandhu,Anil Kumar Sharma